CRF and urocortins and their receptors

CRF 和尿皮质素及其受体

• 批准号: 6956156
• 负责人: WYLIE W. VALE
• 金额: $ 55.19万
• 依托单位: SALK INSTITUTE FOR BIOLOGICAL STUDIES
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-06-01 至 2010-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6956156
• 关键词: binding sites; corticotropin releasing factor; glucagon; hormone receptor; hormone regulation /control mechanism; insulin; laboratory mouse; laboratory rat; pancreatic islet function; pituitary adrenal axis; protein structure function; receptor binding; receptor sensitivity

We are exploring the hypothesis that the Corticotropin Releasing Factor (CRF)/urocortin family of ligands and their cognate receptors play specific and critical roles in the modulation of adaptive responses to stress and other circumstances. In previous granting periods, this Project, with collaborators throughout the Program, characterized CRF, cloned 2 CRF receptors, CRFR1 and CRFR2 and identified urocortin (Ucn) 1, which had high affinity for both receptors. During the last period, we and the Sawchenko Project have found two additional ligands, Ucn 2 and 3, which are highly selective for CRFR2. We have focused on exploring the roles of the N-terminal, first extracellular domain (ECD1) of the CRFRs, which include critical binding sites for peptide agonists and antagonists. We have designed and expressed soluble forms of the ECD1's of CRFR1 and CRFR2beta with retained affinity for appropriate ligands and collaborated with Roland Riek, Salk Institute, to solve the structure of the CRFR2beta-ECD1 by NMR. In the next period, we will work closely with a new project headed by R. Riek, Core C and the Rivier Project to solve the structures of receptor ECD1- ligand complexes for CRFR1, CRFR2alpha and CRFR2beta as well as a novel soluble splice variant comprising mainly the ECD1 of R2alpha. The identification of a protein-protein interaction motif in the ECD1 spawned the testable hypothesis that the functional interaction that we had seen between CRFR2beta and erbB2 in cardiomyocytes may in part depend upon an interaction between the two receptors. Results with mice null for CRFR2 have suggested a variety of roles for this receptor and its ligands in the CNS, cardiovascular system and pancreatic islets. Mice deficient in each of the 3 urocortins have been developed in collaboration with the original Lee project and will be analyzed in this project with respect to the regulation of pituitary/adrenal and pancreatic hormones as well as the expression of CRF-related receptors and remaining ligands. Finally, we will examine the significance of Ucn 3 (and later, Ucn 2), shown to be produced in beta cells and to stimulate insulin and glucagon secretion, as local regulators of islet functions. In the context of the Program, progress in this Project should continue to yield information concerning the molecular nature, regulation and physiologic roles of ligands and receptors of the CRF family and provide insight regarding endocrine, metabolic and stress-related diseases.

我们正在探索促肾上腺皮质激素释放因子(CRF)/尿皮质素家族配体及其同源受体在调节应激和其他环境下的适应性反应中发挥特定和关键作用的假设。在之前的授权期内，本项目与整个项目的合作者一起对CRF进行了表征，克隆了2个CRF受体CRFR1和CRFR2，并鉴定了对这两种受体都具有高亲和力的尿皮质素（Ucn） 1。在过去的一段时间里，我们和Sawchenko项目发现了两个额外的配体，Ucn 2和3，它们对CRFR2具有高度选择性。我们专注于探索crfr的n端，第一细胞外结构域（ECD1）的作用，其中包括肽激动剂和拮抗剂的关键结合位点。我们设计并表达了ECD1的可溶形式